| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.66T | 2.20T | 2.10T | 2.18T | 1.90T |
| Gross Profit | 830.65B | 688.04B | 603.02B | 584.52B | 563.85B |
| EBITDA | 470.31B | 447.40B | 343.36B | 394.28B | 357.37B |
| Net Income | 207.46B | 167.16B | 124.69B | 114.19B | 131.30B |
Balance Sheet | |||||
| Total Assets | 4.43T | 3.54T | 3.42T | 3.15T | 3.15T |
| Cash, Cash Equivalents and Short-Term Investments | 846.43B | 774.61B | 697.05B | 558.33B | 558.33B |
| Total Debt | 618.64B | 608.40B | 685.74B | 752.16B | 679.81B |
| Total Liabilities | 2.22T | 1.73T | 1.70T | 1.68T | 1.68T |
| Stockholders Equity | 2.20T | 1.80T | 1.71T | 1.46T | 1.30T |
Cash Flow | |||||
| Free Cash Flow | 221.69B | 220.55B | 228.42B | -12.94B | -12.94B |
| Operating Cash Flow | 538.29B | 445.84B | 447.01B | 262.77B | 262.77B |
| Investing Cash Flow | -400.53B | -244.84B | -216.59B | -234.40B | -234.40B |
| Financing Cash Flow | -68.65B | -143.33B | -146.37B | 14.95B | 113.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $34.90B | 14.77 | 9.89% | 1.40% | 14.69% | 19.27% | |
75 Outperform | $33.66B | 23.76 | 16.83% | ― | 4.89% | -9.65% | |
74 Outperform | $16.43B | 41.17 | 10.61% | ― | 23.10% | 146.72% | |
70 Outperform | $11.67B | 18.96 | 7.33% | ― | 44.48% | 8.59% | |
69 Neutral | $35.61B | 31.64 | 58.99% | 0.14% | 19.00% | 78.70% | |
63 Neutral | $15.62B | 43.86 | 7.46% | ― | -2.61% | -71.05% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |